Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commission needs nanomaterials definition from SCENIHR by May

This article was originally published in RAJ Devices

Executive Summary

The European Commission has made an urgent request to its Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) for a scientific opinion on the definition of “nanomaterials” by May this year1. Since nanomaterials are used within medicine, this could have an impact on the future regulation of nanomedicine.

UsernamePublicRestriction

Register

SC095955

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel